Leidos Holdings LDOS Health — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Leidos Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Leidos Holdings’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Leidos Holdings's health — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Leidos Holdings's health — revenue?
- Leidos Holdings (LDOS) reported health — revenue of $1.19B in Q1 2026.
- How has Leidos Holdings's health — revenue changed year-over-year?
- Leidos Holdings's health — revenue decreased by 0.0% year-over-year, from $1.19B to $1.19B.
- What is the long-term trend for Leidos Holdings's health — revenue?
- Over 2 years (2021 to 2023), Leidos Holdings's health — revenue has grown at a 9.3% compound annual growth rate (CAGR), from $2.55B to $3.04B.
- What does health — revenue mean?
- Represents the total gross income generated by the Health business segment through the delivery of services and solutions to government and commercial clients. This figure reflects the segment's market share and demand for its specialized health-related technology and consulting offerings.